Furthermore, although TMB and PD‐L1 have served as established biomarkers for patient selection in NSCLC,37, 38 specific markers for direct individualized therapy are currently lacking in patients with ES‐SCLC. Here, CD274 is linked to non-small cell lung carcinoma.